comparemela.com
Home
Live Updates
Biotechnology 121 - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Biotechnology 121 - Page 1 : comparemela.com
2024-04-12 | OTCPK:ENZC | Press Release
(2024-04-12 | OTCPK:ENZC) Update on Formulation of New Business Strategy
United states
Golden gate university
San francisco
Sofiya grad
Harry zhabilov
Lachezar ivanov
Steve sharabura
Diana zhabilov
Gaurav chandra
Steveng sharabura
American institute of chemical engineers
Doctor of medical sciences
While enzolytics inc
Company contact
Cornell university
Health commission
2024-04-01 | NDAQ:SLGL | Press Release | Sol Gel Technologies Ltd
(2024-04-01 | NDAQ:SLGL) Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
United states
New jersey
Arcutis biotherapeutics
Padagis closecurlyquote
Gilad mamlok
Mori arkin
Arcutis closecurlydoublequote
Drug administration
Company closecurlyquote
Company annual report on form
Padagis israel pharmaceuticals ltd closecurlydoublequote
Us district court
Arcutis biotherapeutics inc
Gel technologies ltd
Exchange commission
Gel technologies
2024-02-14 | NDAQ:GLSI | Press Release | Greenwich Lifesciences Inc
(2024-02-14 | NDAQ:GLSI) Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
United states
Baylor college of medicine
Nordrhein westfalen
France general
Baylor university
University hospital
San francisco
Jaye thompson
Miguel martin
Institut curie
Gregorio mara
Joycea oshaughnessy
Forschungs gmb
Mothaffarf rimawi
Francois clement bidard
Williamj gradishar
2024-02-13 | TSXV:TELO | Press Release | Telo Genomics Ord Shs
(2024-02-13 | TSXV:TELO) Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients
United states
Sherif louis
Regulation services provider
Company or telo
Mcgill university
Telo genomics corp
Venture exchange
End results program
Newsfile corp
National library of medicine
Jewish general hospital
National library
Globe newswire
North america
National institute
Note regarding forward looking
2024-02-13 | NDAQ:CRSP | Press Release | CRISPR Therapeutics AG
(2024-02-13 | NDAQ:CRSP) CRISPR Therapeutics Announces $280 Million Registered Direct Offering
City of
United kingdom
United states
San francisco
Rachel eides
Samarth kulkarni
Susan kim
Therapeutics inc
Exchange commission
Vertex pharmaceuticals
Chief executive officer
Nobel prize winning
Forward looking statement
Private securities litigation reform act
Factors closecurlydoublequote
Crispr therapeutics ag
vimarsana © 2020. All Rights Reserved.